Aslan Pharmaceuticals News

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

May 9 19:12

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 7 19:44

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 22 20:35

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 20 05:06

Aslan Pharmaceuticals | 424B5: Prospectus

Apr 12 20:17

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 12 20:12

Aslan Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 12 18:42

Aslan Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report

Apr 12 18:31

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 12 18:07

Aslan Pharmaceuticals | EFFECT: Others

Apr 1 18:06

Aslan Pharmaceuticals | D: Filing D

Mar 29 02:15

Aslan Pharmaceuticals | CORRESP: CORRESP

Mar 29 01:02

Aslan Pharmaceuticals | UPLOAD: Others

Mar 29 01:02

Aslan Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers

Mar 26 04:50

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%), etc.

Mar 22 04:47

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%), etc.

Mar 20 10:29

Aslan Pharmaceuticals | 424B5: Prospectus

Mar 14 18:28

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 13 19:28

Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 11 20:06

Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-K2 HealthVentures Equity Trust LLC(5.2%),Parag Shah(5.2%), etc.

Feb 15 05:50